Elderly NSCLC/D vs DP (JCOG0207)

NCT00190476 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

230

Enrollment

OTHER

Sponsor class

Conditions

Non-small-cell Lung Cancer

Interventions

DRUG: Weekly docetaxel alone
DRUG: Weekly docetaxel + cisplatin combination

Sponsor

Japan Clinical Oncology Group

Collaborators

[object Object]